Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01063010
Recruitment Status : Withdrawn (no participants enrolled)
First Posted : February 5, 2010
Last Update Posted : March 16, 2017
The Cooper Health System
Carolinas Medical Center
Information provided by (Responsible Party):
Nathan Shapiro, Beth Israel Deaconess Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : January 2015
  Estimated Study Completion Date : January 2015
Publications automatically indexed to this study by Identifier (NCT Number):